Thoratec faulty heart pump linked to five deaths

TriMed Staff | | Health Imaging | Diagnostic Imaging
 
HeartMate II left ventricular assist device (above) associated with adverse events. Image Source: Thoratec Corporation 
Thoratec has warned that its HeartMate II blood pump may fail due to a defective lead that connects the heart pump with the system controller. At least 27 people have required surgery to replace the mechanical heart, and five deaths have been linked to the HeartMate lead problems.

The lead has been found to wear or fatigue over time, potentially interrupting pump function, according to the Pleasanton, Calif.-based company. The warning applies to HeartMate II Left Ventricular Assist Systems (HM II LVAS) with catalogue numbers 1355 to 102139, which can be found on the package’s label..

According to a notice issued on Oct. 24, Thoratec estimated that the probability a patient will require a replacement of their heart pump due to a damaged percutaneous lead is approximately 1.3 percent at 12 months, 6.5 percent at 24 months and 11.4 percent at 36 months.

These reports occurred over five years of clinical experience with 1,972 implants, the FDA said. All patients who have undergone a replacement of the HeartMate II pump survived the operation and were alive at least 30 days postoperatively. In five cases, pump replacement was not feasible and the patients expired.

The affected systems were distributed to 153 hospitals and distributors throughout the U.S., Europe, Canada and other countries.

TriMed Staff

Related Content

First human X-rays in space to take place during upcoming SpaceX mission
Mycoplasma pneumonia: Experts highlight imaging findings linked to the pediatric diagnosis
AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.